These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15282869)

  • 61. [Pharmacological interactions in co-infected patients].
    Jáuregui Rueda H; Toibaro J
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S64-7; discussion S74-82. PubMed ID: 16862866
    [No Abstract]   [Full Text] [Related]  

  • 62. Hepatitis coinfection and LPV/RTV.
    Carter M
    IAPAC Mon; 2004 Oct; 10(10):398. PubMed ID: 15801120
    [No Abstract]   [Full Text] [Related]  

  • 63. [Update on the treatment of hepatitis B virus infection in patients infected by the human immunodeficiency virus].
    Benhamou Y
    Med Mal Infect; 2004 Nov; 34 Spec No 2():27-9. PubMed ID: 15801538
    [No Abstract]   [Full Text] [Related]  

  • 64. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection.
    Hofmann WP; Soriano V; Zeuzem S
    Handb Exp Pharmacol; 2009; (189):321-46. PubMed ID: 19048206
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Co-infections. Hepatitis C virus--some background information.
    TreatmentUpdate; 2008; 20(3):5-8. PubMed ID: 18661654
    [No Abstract]   [Full Text] [Related]  

  • 66. HCV/HIV co-infection II: sobriety and treatment.
    Moreno G
    Posit Aware; 2002; 13(2):27-8. PubMed ID: 12001925
    [No Abstract]   [Full Text] [Related]  

  • 67. [The combination administration of interferon in viral hepatitis].
    Zhao GD; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):5-7. PubMed ID: 21272449
    [No Abstract]   [Full Text] [Related]  

  • 68. Ribozymes as antiviral agents.
    Bartolomé J; Castillo I; Carreño V
    Minerva Med; 2004 Feb; 95(1):11-24. PubMed ID: 15041923
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Viral hepatitis treatment and beyond: a review of CROI 2005.
    Wilson L; Gebo K
    Hopkins HIV Rep; 2005 May; 17(3):10-1, 16. PubMed ID: 16419312
    [No Abstract]   [Full Text] [Related]  

  • 70. Antiretroviral therapy in patients with hepatitis and HIV: weighing risks and benefits.
    Powderly WG
    Clin Infect Dis; 2004 Mar; 38 Suppl 2():S109-13. PubMed ID: 14986283
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Treatment of hepatitis B and C virus infection].
    Trautwein C; Tacke F
    Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S87-9. PubMed ID: 12817332
    [No Abstract]   [Full Text] [Related]  

  • 72. [New domestic phospholipid preparation "Fosfogliv" as an effective treatment for patients with acute viral hepatitis].
    Uchaĭkin VF; Luchshev VI; Zharov SN; Kovalev OB; Ipatova OM; Tikhonova EG; Torkhovskaia TI; Kniazhev VA; Dunaevskiĭ OA; Archakov AI
    Klin Med (Mosk); 2000; 78(5):39-42. PubMed ID: 10881509
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Common hepatitis B drug linked to HIV antiviral resistance.
    Future Microbiol; 2007 Apr; 2(2):104. PubMed ID: 17687802
    [No Abstract]   [Full Text] [Related]  

  • 74. Defining the standard of care: randomized controlled trials for the treatment of hepatitis C in the HIV-infected person.
    Sulkowski MS
    Hepatology; 2004 Apr; 39(4):906-8. PubMed ID: 15057892
    [No Abstract]   [Full Text] [Related]  

  • 75. Managing HIV/HBV coinfection can challenge some clinicians.
    Murphy MJ
    HIV Clin; 2003; 15(4):6-9. PubMed ID: 14672056
    [No Abstract]   [Full Text] [Related]  

  • 76. New warning for ddI.
    AIDS Patient Care STDS; 2002 Dec; 16(12):618. PubMed ID: 12879533
    [No Abstract]   [Full Text] [Related]  

  • 77. Immunodeficiency and new treatment for HBV.
    Benhamou Y
    Nurs Stand; 1995 Mar 1-7; 9(23):14. PubMed ID: 7703142
    [No Abstract]   [Full Text] [Related]  

  • 78. Current world literature.
    Curr Opin HIV AIDS; 2011 Nov; 6(6):566-70. PubMed ID: 21996925
    [No Abstract]   [Full Text] [Related]  

  • 79. Highlights from the 60th Annual Meeting of the AASLD.
    Mayor S
    Lancet Infect Dis; 2010 Jan; 10(1):8. PubMed ID: 20162852
    [No Abstract]   [Full Text] [Related]  

  • 80. Antiviral therapies for hepatitis-related glomerulonephritis.
    Kanaan N; Goffin E
    Lancet; 2005 Jul 16-22; 366(9481):203. PubMed ID: 16023508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.